A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Immunology Bookmark and Share

Immunology

City of Hope’s Department of Immunology, one ofeight major basic science (“Laboratory Research”) departments of the Beckman Research Institute, was established in 1972 by Charles Todd. At that time, immune-based therapies were used on a very limited basis in cancer treatment, reserved for conditions such as malignant melanoma and bladder cancer. Most immunotherapy treatments consisted of agents such as BCG and interferon.

In recent years, the field of cancer immunology has grown by leaps and bounds, and a wide range of neoplastic diseases, including both hematologic malignancies and solid tumors,are routinely being treated with a well-stocked armamentarium of monoclonal antibodies and other immunotherapy methods.

The Department of Immunology continues its original vision, with a dual focus on both immunology and structural biology. It has seven principal investigators with research interests in cell and tumor immunology and structure analysis, who are aided by state-of-the-art facilities in mass spectrometry and NMR, as well as a computer cluster for computational chemistry.

The unique combination of biological and structural studies and the intensive exploration of structure-function relationships have created a thriving, productive environment that has encouraged fruitful collaboration among investigators at City of Hope and at other institutions.
 
Laboratory Research

John Shively, Ph.D. -  CEA (carcinoembryonic antigen) gene family
Dr. Shively's lab specializes in the CEA (carcinoembryonic antigen) gene family. In particular, he is researching the use of anti-CEA antibodies for tumor imaging and therapy and the role of CEACAM1 in T-cell activation and mammary epithelial cell polarization.  He is also exploring the relationship of the immune system and genetics to fibromyalgia.
 
Terry Lee, Ph.D. - Optimizing the application of biomolecule mass spectrometry
Dr. Lee’s focus is optimizing the application of biomolecule mass spectrometry to “real-world” biological problems. He develops new methods for proteomic analyses by mass spectrometry including integrated microfluidic systems for sample preparation and automated methods of data acquisition and analysis.
 
Markus Kalkum, Ph.D. - Develops novel biochemical and mass spectrometric methods
Dr. Kalkum develops novel biochemical and mass spectrometric methods for the sensitive detection of functional biomolecules in complex samples. His goal is to improve the early diagnosis of emerging and frequently under-diagnosed diseases, including opportunistic fungal and bacterial infections common in transplant recipients.
 
Nagarajan Vaidehi, Ph.D. - Devises computational approaches
Dr. Vaidehi devises computational approaches to study the structure, function and dynamics of G-protein coupled receptors. Of particular interest is the interaction of chemokines, and antagonists to the chemokine receptors, that trigger leukocyte migration in immune response and inflammation. By predicting binding-site interactions of agonists and antagonists with the receptors, the drug development process is greatly streamlined.
 
Zuoming Sun, Ph.D. - Studies the mechanisms controlling T-cell activation and survival
Dr. Sun’s lab studies the mechanisms controlling T-cell activation and survival. Activation and survival of T-lymphocytes control the quality and magnitude of immune response. Manipulation of T-cell activity is therefore one of the most important treatments for 1) enhancing immune responses against pathogens and tumors and 2) inhibiting the immune responses involved in autoimmune diseases and transplant rejection.
 

Immunology Faculty

Immunology

Immunology

City of Hope’s Department of Immunology, one ofeight major basic science (“Laboratory Research”) departments of the Beckman Research Institute, was established in 1972 by Charles Todd. At that time, immune-based therapies were used on a very limited basis in cancer treatment, reserved for conditions such as malignant melanoma and bladder cancer. Most immunotherapy treatments consisted of agents such as BCG and interferon.

In recent years, the field of cancer immunology has grown by leaps and bounds, and a wide range of neoplastic diseases, including both hematologic malignancies and solid tumors,are routinely being treated with a well-stocked armamentarium of monoclonal antibodies and other immunotherapy methods.

The Department of Immunology continues its original vision, with a dual focus on both immunology and structural biology. It has seven principal investigators with research interests in cell and tumor immunology and structure analysis, who are aided by state-of-the-art facilities in mass spectrometry and NMR, as well as a computer cluster for computational chemistry.

The unique combination of biological and structural studies and the intensive exploration of structure-function relationships have created a thriving, productive environment that has encouraged fruitful collaboration among investigators at City of Hope and at other institutions.
 
Laboratory Research

John Shively, Ph.D. -  CEA (carcinoembryonic antigen) gene family
Dr. Shively's lab specializes in the CEA (carcinoembryonic antigen) gene family. In particular, he is researching the use of anti-CEA antibodies for tumor imaging and therapy and the role of CEACAM1 in T-cell activation and mammary epithelial cell polarization.  He is also exploring the relationship of the immune system and genetics to fibromyalgia.
 
Terry Lee, Ph.D. - Optimizing the application of biomolecule mass spectrometry
Dr. Lee’s focus is optimizing the application of biomolecule mass spectrometry to “real-world” biological problems. He develops new methods for proteomic analyses by mass spectrometry including integrated microfluidic systems for sample preparation and automated methods of data acquisition and analysis.
 
Markus Kalkum, Ph.D. - Develops novel biochemical and mass spectrometric methods
Dr. Kalkum develops novel biochemical and mass spectrometric methods for the sensitive detection of functional biomolecules in complex samples. His goal is to improve the early diagnosis of emerging and frequently under-diagnosed diseases, including opportunistic fungal and bacterial infections common in transplant recipients.
 
Nagarajan Vaidehi, Ph.D. - Devises computational approaches
Dr. Vaidehi devises computational approaches to study the structure, function and dynamics of G-protein coupled receptors. Of particular interest is the interaction of chemokines, and antagonists to the chemokine receptors, that trigger leukocyte migration in immune response and inflammation. By predicting binding-site interactions of agonists and antagonists with the receptors, the drug development process is greatly streamlined.
 
Zuoming Sun, Ph.D. - Studies the mechanisms controlling T-cell activation and survival
Dr. Sun’s lab studies the mechanisms controlling T-cell activation and survival. Activation and survival of T-lymphocytes control the quality and magnitude of immune response. Manipulation of T-cell activity is therefore one of the most important treatments for 1) enhancing immune responses against pathogens and tumors and 2) inhibiting the immune responses involved in autoimmune diseases and transplant rejection.
 

Immunology Faculty

Immunology Faculty

Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...
  • Geoff Berman, 61, starts his day with the motto: “The sun is up. I’m vertical. It’s a good day.” Ever since he’s been in remission from lymphoma, Berman makes a special point of being grateful for each day, reminding himself that being alive is a gift. “I just enjoy living,” he said. “I give e...
  • Neural stem cells have a natural ability to seek out cancer cells in the brain. Recent research from the laboratories of Michael Barish, Ph.D., and Karen Aboody, M.D., may offer a new explanation for this attraction between stem cells and tumors. Prior to joining City of Hope, Aboody, now a professor in the Dep...
  • The American Society of Clinical Oncology, a group that includes more than 40,000 cancer specialists around the country, recently issued a list of the five most profound cancer advances over the past five decades. Near the top of the list was the introduction of chemotherapy for testicular cancer. To many in th...
  • “The dying, as a group, have been horribly underserved.” So says Bonnie Freeman, R.N., D.N.P., A.N.P.-B.C., A.C.H.P.N., a nurse practitioner in the Department of Supportive Care Medicine at City of Hope. After nearly 25 years, primarily in critical care nursing, Freeman saw that the needs of the dying were ofte...
  • “Are we the only ones who feel this way?” Courtney Bitz, L.C.S.W., a social worker in the Sheri & Les Biller Patient and Family Resource Center at City of Hope, often hears this question from couples trying to cope with a breast cancer diagnosis and still keep their relationship strong. The ques...
  • Diabetes investigators at City of Hope are studying the full trajectory of diabetes and metabolic disorders, as well as complications of the disease. One especially promising approach focuses on proteins known as growth factors. Led by Fouad Kandeel, M.D., Ph.D., chair and professor of the Department of Clinica...
  • Acute myeloid leukemia is the most common form of acute leukemia among adults, accounting for 18,000 diagnoses in 2014. Two decades ago, in 1996, the National Comprehensive Cancer Network (NCCN) published its first guidelines for treatment of acute myeloid leukemia, or AML. Margaret O’Donnell, M.D., assoc...
  • Children diagnosed with cancer are more likely than ever before to survive the disease, but with a potential new set of health problems caused by the cancer treatment itself. Those problems can particularly affect the heart, and as doctors and other health care workers try to assess how best to care for this sp...
  • Karen Reckamp, M.D., M.S., has an office next to my own, and we often see patients at the same time. As such, I’ve gotten to know her quite well over the years, and I’ve also gotten a glimpse of many of her patients. She specializes in lung cancer, and most of her patients have tumors […]
  • Today is National Doctors Day, the official day to recognize, thank and celebrate the tremendous work physicians do each and every day. Launched in 1991 via a presidential proclamation from then-President George Bush, the observance offers a chance to reflect on the qualities that define truly great medical car...
  • When considering cancer risk, categories like “women’s cancers” and “men’s cancers” may not matter. A complete medical history, especially of first-degree relatives, must be considered when evaluating risk. A new study drives home that fact. Published in the journal Cancer, the study found a link between a fami...
  • Precision medicine holds promise – on that doctors, especially cancer specialists, can agree. But this sophisticated approach to treatment, which incorporates knowledge about a person’s genetic profile, environment and lifestyle, isn’t yet standard for all cancers. It can’t be. Researchers and scientists are st...
  • Frank Di Bella, 70, is on a mission: Find a cure for metastatic bladder cancer. It’s just possible he might. Although Di Bella isn’t a world-renowned physician, cancer researcher or scientist, he knows how to make things happen. For more than 20 years, he served as chairman of annual fundraising gal...
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling aplomb. Furt...